Endocrine Pathology

Papers
(The H4-Index of Endocrine Pathology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Overview of the 2022 WHO Classification of Thyroid Neoplasms369
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms212
Overview of the 2022 WHO Classification of Pituitary Tumors163
Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas105
Overview of the 2022 WHO Classification of Parathyroid Tumors89
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors81
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?46
Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites39
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Orig34
Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice33
What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics32
Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing31
Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations30
Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithe29
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry28
Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification26
Histopathologic Assessment of Capsular Invasion in Follicular Thyroid Neoplasms—an Observer Variation Study25
Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors25
Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis24
Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes23
Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification23
Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?22
Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors22
0.064019203186035